AGING

• Interrelationships among HDL metabolism, aging, and atherosclerosis.
  (Walter M. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1244-50. Epub 2009 Aug 10. Review.)
  View Abstract

• A high lipoprotein(a) level confers approximately equal positive effects on coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases.
  (Sawabe M, et al. Heart. 2009 Aug 25. [Epub ahead of print])
  View Abstract
• Variation in paraoxonase-1 activity and atherosclerosis.
  (Soran H, et al. Curr Opin Lipidol. 2009 Aug;20(4):265-74.)
  View Abstract
• Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
  (Vaverkova H, et al. Clin Biochem. 2009 Aug;42(12):1246-51. Epub 2009 May 18.)
  View Abstract
• Oxidative modification of LDL: its pathological role in atherosclerosis.
  (Itabe H. Clin Rev Allergy Immunol. 2009 Aug;37(1):4-11.)
  View Abstract

• Biomarkers of premature atherosclerosis.
  (Kampoli AM, et al. Trends Mol Med. 2009 Jul;15(7):323-32. Epub 2009 Jul 3. Review.)
  View Abstract
• The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome.
  (Drager LF, et al. Atherosclerosis. 2009 Aug 19. [Epub ahead of print])
  View Abstract
• Polymorphism in the IL10 promoter region and early markers of atherosclerosis: The Cardiovascular Risk in Young Finns Study.
  (Heiskanen M, et al. Atherosclerosis. 2009 Jul 8. [Epub ahead of print])
  View Abstract
• Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
  (Söder PO, et al. J Periodontal Res. 2009 Aug;44(4):452-8. Epub 2008 Oct 22.)
  View Abstract
• Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
  (Matsuo M, et al. Clin Chem. 2009 Aug 6. [Epub ahead of print])
  View Abstract

• Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.
  (Hanley AJ, et al. Diabetologia. 2009 Oct;52(10):2079-86. Epub 2009 Jul 31.)
  View Abstract
• Relationships between serum osteocalcin versus serum glucose and lipids levels and atherosclerosis in type 2 diabetes mellitus.
  (Kanazawa I, et al. J Bone Miner Res. 2009 Jul 13. [Epub ahead of print])
  View Abstract
• Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
  (Lloyd DJ, et al. Diabetes Obes Metab. 2009 Jul;11(7):688-99.)
  View Abstract
• Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes.
  (Park SW, et al. Atherosclerosis. 2009 Jul;205(1):309-13. Epub 2008 Dec 13.)
  View Abstract
• Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
  (Stamatelopoulos KS, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1702-8. Epub 2009 Jul 16.)
  View Abstract

DIET, NUTRITION, AND METABOLISM

• Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis.
  (Liu L, et al. Am J Clin Nutr. 2009 Aug;90(2):362-8. Epub 2009 Jun 10.)
  View Abstract
• Adherence to 2005 Dietary Guidelines for Americans is associated with a reduced progression of coronary artery atherosclerosis in women with established coronary artery disease.
  (Imamura F, et al. Am J Clin Nutr. 2009 Jul;90(1):193-201. Epub 2009 May 13.)
  View Abstract
• An SOD rich melon extract Extramel((R)) prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis.
  (Décordé K, et al. Nutr Metab Cardiovasc Dis. 2009 Aug 18. [Epub ahead of print])
  View Abstract
• Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study.
  (Liese AD, et al. Diabetes Care. 2009 Aug;32(8):1434-6. Epub 2009 Jun 1.)
  View Abstract
• trans-Fatty acids in the diet stimulate atherosclerosis.
  (Bassett CM, et al. Metabolism. 2009 Jul 22. [Epub ahead of print])
  View Abstract
• Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis.
  (Khanna AK. J Biomed Sci. 2009 Jul 15;16:66.)
  View Abstract
• Fast-food consumption, diet quality, and neighborhood exposure to fast food: the multi-ethnic study of atherosclerosis.
  (Moore LV, et al. Am J Epidemiol. 2009 Jul 1;170(1):29-36. Epub 2009 May 8.)
  View Abstract
• Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
  (Nettleton JA, et al. Am J Clin Nutr. 2009 Sep;90(3):647-54. Epub 2009 Jul 22.)
  View Abstract
• Role of dietary mutagens in cancer and atherosclerosis.
  (Ferguson LR. Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):343-9. Review.)
  View Abstract
• Plasma phospholipid EPA and DHA in relation to atherosclerosis in 61-year-old men.
  (Lindqvist HM, et al. Atherosclerosis. 2009 Aug;205(2):574-8. Epub 2008 Dec 30.)
  View Abstract
• Binge drinking and the progression of atherosclerosis in middle-aged men: an 11-year follow-up.
  (Rantakömi SH, et al. Atherosclerosis. 2009 Jul;205(1):266-71. Epub 2008 Nov 18.)
  View Abstract

DRUG THERAPY

• Eplerenone does not attenuate diabetes-associated atherosclerosis.
  (Koh PJ, et al. J Hypertens. 2009 Jul;27(7):1431-8.)
  View Abstract
• A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development.
  (Zhao L, et al. Biochem Pharmacol. 2009 Aug 15;78(4):315-25. Epub 2009 Mar 24.)
  View Abstract
• Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
  (David S, et al. J Hypertens. 2009 Aug;27(8):1641-7.)
  View Abstract
• Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis.
  (Nagy N, et al. Basic Res Cardiol. 2009 Aug 23. [Epub ahead of print])
  View Abstract
• Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis.
  (Largo R, et al. Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H268-76. Epub 2009 May 1.)
  View Abstract
• Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.
  (Delaney JA, et al. Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):545-53.)
  View Abstract
• Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance.
  (Varghese A, et al. J Cardiovasc Magn Reson. 2009 Jul 27;11(1):24.)
  View Abstract
• Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
  (Drexel H, et al. Atherosclerosis. 2009 Aug 21. [Epub ahead of print])
  View Abstract
• Effect of dehydroepiandrosterone on atherosclerosis in apolipoprotein E-deficient mice.
  (Yamakawa T, et al. J Atheroscler Thromb. 2009 Aug;16(4):501-8. Epub 2009 Aug 27.)
  View Abstract
• Intensive glucose lowering therapy reduces cardiovascular disease events in VADT participants with lower calcified coronary atherosclerosis.
  (Reaven PD, et al. Diabetes. 2009 Aug 3. [Epub ahead of print])
  View Abstract
• Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
  (Hiro T, et al. J Am Coll Cardiol. 2009 Jul 21;54(4):293-302.)
  View Abstract
• Pharmacotherapy of coronary atherosclerosis.
  (Finn AV, et al. Expert Opin Pharmacother. 2009 Jul;10(10):1587-603.)
  View Abstract
• Statins inhibit Rho kinase activity in patients with atherosclerosis.
  (Nohria A, et al. Atherosclerosis. 2009 Aug;205(2):517-21. Epub 2008 Dec 24.)
  View Abstract Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
  (Liu G, et al. J Ethnopharmacol. 2009 Aug 22. [Epub ahead of print])
  View Abstract
• 7-difluoromethyl-5,4'-dimethoxygenistein, a Novel Genistein Derivative, has Therapeutic Effects on Atherosclerosis in a Rabbit Model.
  (Zhao H, et al. J Cardiovasc Pharmacol. 2009 Aug 28. [Epub ahead of print])
  View Abstract
• Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation.
  (Guo ZJ, et al. Int J Cardiol. 2009 Aug 21;136(3):315-24. Epub 2009 Jan 29.)
  View Abstract
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
  (Zhang LN, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1265-70. Epub 2009 Aug 10.)
  View Abstract
• Modulatory effect of Inula racemosa Hook. f. (Asteraceae) on experimental atherosclerosis in guinea-pigs.
  (Mangathayaru K, et al. J Pharm Pharmacol. 2009 Aug;61(8):1111-8.)
  View Abstract

EPIDEMIOLOGY

• Do socioeconomic gradients in subclinical atherosclerosis vary according to acculturation level? Analyses of Mexican-Americans in the multi-ethnic study of atherosclerosis.
  (Gallo LC, et al. Psychosom Med. 2009 Sep;71(7):756-62. Epub 2009 Aug 6.)
  View Abstract
• Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.
  (Ghosh P, et al. Clin Rheumatol. 2009 Jul 19. [Epub ahead of print])
  View Abstract
• Epidemiology of atherosclerosis in systemic lupus erythematosus.
  (Nikpour M, et al. Curr Rheumatol Rep. 2009 Aug;11(4):248-54.)
  View Abstract
• Are immigrant enclaves healthy places to live? The Multi-ethnic Study of Atherosclerosis.
  (Osypuk TL, et al. Soc Sci Med. 2009 Jul;69(1):110-20. Epub 2009 May 8.)
  View Abstract
• Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis.
  (Aiello AE, et al. Brain Behav Immun. 2009 Jul;23(5):663-71. Epub 2008 Dec 25.)
  View Abstract

GENETICS OF CARDIOVASCULAR DISEASE

• Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction.
  (Andreassi MG. Mutat Res. 2009 Jul 10;667(1-2):35-43. Epub 2008 Nov 5.)
  View Abstract
• Rhythm changes of clock genes, apoptosis-related genes and atherosclerosis-related genes in apolipoprotein E knockout mice.
  (Xu C, et al. Can J Cardiol. 2009 Aug;25(8):473-9.)
  View Abstract
• Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
  (Chien KL, et al. Transl Res. 2009 Sep;154(3):133-41. Epub 2009 Jul 9.)
  View Abstract
• Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
  (Junyent M, et al. Atherosclerosis. 2009 Aug 8. [Epub ahead of print])
  View Abstract
• The HMG-CoA reductase gene and lipid and lipoprotein levels: the multi-ethnic study of atherosclerosis.
  (Chen YC, et al. Lipids. 2009 Aug;44(8):733-43. Epub 2009 Jun 25.)
  View Abstract
• Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia.
  (Yilmaz E, et al. Mol Biol Rep. 2009 Aug 11. [Epub ahead of print])
  View Abstract
• Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
  (Fan YM, et al. Clin Genet. 2009 Jul;76(1):46-53. Epub 2009 Jun 22.)
  View Abstract
• TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis.
  (Gong HP, et al. Diabetes Care. 2009 Jul;32(7):1311-3. Epub 2009 Apr 23.)
  View Abstract
• ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study.
  (Levula M, et al. Ann Med. 2009 Jul 2:1-11. [Epub ahead of print])
  View Abstract
• A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.
  (Olofsson PS, et al. Circ J. 2009 Aug;73(8):1531-6. Epub 2009 Jul 3.)
  View Abstract
• Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals.
  (Kaur-Knudsen D, et al. Pharmacogenomics J. 2009 Aug 4. [Epub ahead of print])
  View Abstract
• A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).
  (Rich SS, et al. Diabetologia. 2009 Jul;52(7):1326-33. Epub 2009 May 9.)
  View Abstract
• Genetic contribution to variation in atherothrombotic phenotypes in the Asian Indian population. The Indian Atherosclerosis Research Study.
  (Rao VS, et al. Thromb Haemost. 2009 Aug;102(2):379-88.)
  View Abstract
• Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis.
  (Fernández-Hernando C, et al. Cell Metab. 2009 Jul;10(1):48-54.)
  View Abstract
• Novel quantitative trait locus is mapped to chromosome 12p11 for left ventricular mass in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis.
  (Wang L, et al. BMC Med Genet. 2009 Jul 23;10:74.)
  View Abstract
• Heritability and linkage analysis for carotid intima-media thickness: the family study of stroke risk and carotid atherosclerosis.
  (Sacco RL, et al. Stroke. 2009 Jul;40(7):2307-12. Epub 2009 Jun 4.)
  View Abstract
• Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
  (Gordts PL, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1258-64. Epub 2009 Aug 10.)
  View Abstract

HYPERTENSION

• Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis.
  (Kawasaki R, et al. J Hypertens. 2009 Aug 12. [Epub ahead of print])
  View Abstract
• Association between wall shear stress and carotid atherosclerosis in patients with never treated essential hypertension.
  (Lee MY, et al. Am J Hypertens. 2009 Jul;22(7):705-10. Epub 2009 Apr 30.)
  View Abstract
• Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis.
  (Shrestha I, et al. Hypertens Res. 2009 Jul 31. [Epub ahead of print])
  View Abstract

IMAGING

• Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.
  (Krasinski A, et al. Ultrasound Med Biol. 2009 Jul 31. [Epub ahead of print])
  View Abstract
• Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.
  (Choudhury RP, et al. Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):983-91. Epub 2009 Feb 12. Review.)
  View Abstract
• Multiple imputation for missing with cardiac magnetic resonance imaging data: results from the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Delaney JA, et al. Can J Cardiol. 2009 Jul;25(7):e232-5.)
  View Abstract
• Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
  (Haider N, et al. J Nucl Cardiol. 2009 Sep-Oct;16(5):753-62. Epub 2009 Aug 7.)
  View Abstract
• Optical and multimodality molecular imaging: insights into atherosclerosis.
  (Jaffer FA, et al. Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1017-24. Epub 2009 Apr 9. Review.)
  View Abstract
• Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.
  (Nahrendorf M, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1444-51. Epub 2009 Jul 16.)
  View Abstract
• Imaging coronary and extracoronary atherosclerosis: feasibility and impact of whole-body computed tomography angiography.
  (Napoli A, et al. Eur Radiol. 2009 Jul;19(7):1704-14. Epub 2009 Mar 11.)
  View Abstract
• Inflammation imaging in atherosclerosis.
  (Rudd JH, et al. Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1009-16. Epub 2009 Mar 20. Review.)
  View Abstract
• Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis?
  (Santos RD, et al. Atherosclerosis. 2009 Aug;205(2):349-56. Epub 2008 Dec 14.)
  View Abstract
• Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
  (Açikel M, et al. Anadolu Kardiyol Derg. 2009 Aug;9(4):273-9.)
  View Abstract
• Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.
  (Bayturan O, et al. JACC Cardiovasc Interv. 2009 Jul;2(7):672-8.)
  View Abstract
• Contrast-enhanced MRI of carotid atherosclerosis: dependence on contrast agent.
  (Kerwin WS, et al. J Magn Reson Imaging. 2009 Jul;30(1):35-40.)
  View Abstract
• Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations.
  (Mintz GS, et al. Circ J. 2009 Sep;73(9):1557-60. Epub 2009 Jul 29.)
  View Abstract
• Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis.
  (Mok M, et al. Scand J Rheumatol. 2009 Jul 7:1-5. [Epub ahead of print])
  View Abstract
• Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population.
  (Hansen T, et al. Atherosclerosis. 2009 Jul;205(1):163-7. Epub 2008 Nov 18.)
  View Abstract
• Prevalence of myocardial bridging and correlation with coronary atherosclerosis studied with 64-slice CT coronary angiography.
  (La Grutta L, et al. Radiol Med. 2009 Aug 20. [Epub ahead of print])
  View Abstract
• Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions.
  (Ueno K, et al. Circ J. 2009 Aug 19. [Epub ahead of print])
  View Abstract

IMMUNOLOGY

• Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
  (Lewis MJ, et al. Circulation. 2009 Aug 4;120(5):417-26. Epub 2009 Jul 20.)
  View Abstract
• Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
  (Lopez LR, et al. Clin Rev Allergy Immunol. 2009 Aug;37(1):12-9.)
  View Abstract
• Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.
  (Ames PR, et al. Clin Rev Allergy Immunol. 2009 Aug;37(1):29-35.)
  View Abstract
• Experimental immunotherapeutic approaches for atherosclerosis.
  (Amir S, et al. Clin Immunol. 2009 Aug 8. [Epub ahead of print])
  View Abstract
• Adaptive immunity and atherosclerosis.
  (Andersson J, et al. Clin Immunol. 2009 Jul 25. [Epub ahead of print])
  View Abstract
• Chronic infections and atherosclerosis.
  (Ayada K, et al. Clin Rev Allergy Immunol. 2009 Aug;37(1):44-8.)
  View Abstract
• Pentraxins, anti-pentraxin antibodies, and atherosclerosis.
  (Bassi N, et al. Clin Rev Allergy Immunol. 2009 Aug;37(1):36-43.)
  View Abstract
• Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
  (Zinger H, et al. Clin Rev Allergy Immunol. 2009 Aug;37(1):20-8.)
  View Abstract
• Effect of natural killer T cell activation on the initiation of atherosclerosis.
  (van Puijvelde GH, et al. Thromb Haemost. 2009 Aug;102(2):223-30.)
  View Abstract
• Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study.
  (Tien PC, et al. AIDS. 2009 Aug 24;23(13):1781-4.)
  View Abstract
• Alzheimer's disease and atherosclerosis: passers-by or brothers?
  (Xing Y, et al. Med Hypotheses. 2009 Aug;73(2):138-9. Epub 2009 Apr 23.)
  View Abstract
• HIV positivity, protease inhibitor exposure, and subclinical atherosclerosis: A systematic review and meta-analysis of observational studies.
  (Hulten E, et al. Heart. 2009 Jul 23. [Epub ahead of print])
  View Abstract
• The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
  (Engel D, et al. Semin Immunol. 2009 Jul 16. [Epub ahead of print])
  View Abstract

INNOVATIVE TECHNIQUES / MODELING

• Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis.
  (Nam D, et al. Am J Physiol Heart Circ Physiol. 2009 Aug 14. [Epub ahead of print])
  View Abstract
• Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis.
  (Park K, et al. Int J Impot Res. 2009 Jul-Aug;21(4):228-34. Epub 2009 Jun 18.)
  View Abstract
• Can scavenger receptor Class B Type I loaded ultrasound contrast agent be a new method for treating atherosclerosis?
  (Jiang Y, et al. Med Hypotheses. 2009 Jul;73(1):36-7. Epub 2009 Mar 6.)
  View Abstract

• Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
  (Chung CP, et al. Lupus. 2009 Aug;18(9):799-806.)
  View Abstract
• Which components of malnutrition-inflammation-atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy?
  (Jakuszewski P, et al. Nephrology (Carlton). 2009 Jul 9. [Epub ahead of print])
  View Abstract
• Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans.
  (Liu SW, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):202-7. Epub 2008 Oct 20.)
  View Abstract
• Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
  (Norata GD, et al. Circulation. 2009 Aug 25;120(8):699-708. Epub 2009 Aug 10.)
  View Abstract
• Inflammatory mechanisms in atherosclerosis.
  (Hansson GK. J Thromb Haemost. 2009 Jul;7 Suppl 1:328-31.)
  View Abstract
• Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.
  (Merino VF, et al. J Mol Med. 2009 Jul 18. [Epub ahead of print])
  View Abstract
• Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis.
  (Wang H, et al. Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1046-52. Epub 2009 Apr 30.)
  View Abstract
• Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.
  (McMahon M, et al. Arthritis Rheum. 2009 Aug;60(8):2428-37.)
  View Abstract
• Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
  (Lehrke M, et al. Eur J Endocrinol. 2009 Aug;161(2):339-44. Epub 2009 Jun 4.)
  View Abstract
• Relationships of soluble E-selectin and high-sensitivity C-reactive protein with carotid atherosclerosis in Japanese men.
  (Sakurai S, et al. J Atheroscler Thromb. 2009 Aug;16(4):339-45. Epub 2009 Aug 11.)
  View Abstract
• Atherosclerosis in survivors of Kawasaki disease.
  (Gupta-Malhotra M, et al. J Pediatr. 2009 Jul 10. [Epub ahead of print])
  View Abstract

• Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
  (Wang CC, et al. J Gastroenterol Hepatol. 2009 Aug;24(8):1411-6.)
  View Abstract
• Smoking and coronary atherosclerosis: follow-up study in China.
  (Jia EZ, et al. Clin Exp Pharmacol Physiol. 2009 Jul;36(7):690-5.)
  View Abstract

MENOPAUSE

• Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors.
  (Georgiopoulos GA, et al. Hypertension. 2009 Jul;54(1):98-105. Epub 2009 May 18.)
  View Abstract
• Carotid atherosclerosis and the risk factors in early postmenopausal Chinese women.
  (Yu RH, et al. Maturitas. 2009 Jul 20;63(3):233-9. Epub 2009 May 13.)
  View Abstract

METABOLIC SYNDROME

• The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis.
  (Holewijn S, et al. J Clin Endocrinol Metab. 2009 Aug;94(8):2893-9. Epub 2009 May 5.)
  View Abstract

OBESITY

• Admixture mapping of obesity-related traits in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study.
  (Cheng CY, et al. Obesity (Silver Spring). 2009 Aug 20. [Epub ahead of print])
  View Abstract
• Monocyte heterogeneity in obesity and subclinical atherosclerosis.
  (Rogacev KS, et al. Eur Heart J. 2009 Aug 17. [Epub ahead of print])
  View Abstract
• Social stress, visceral obesity, and coronary artery atherosclerosis in female primates.
  (Shively CA, et al. Obesity (Silver Spring). 2009 Aug;17(8):1513-20. Epub 2009 Mar 26.)
  View Abstract
• Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects.
  (Konishi K, et al. Diabetes Res Clin Pract. 2009 Aug;85(2):171-8. Epub 2009 May 30.)
  View Abstract

• The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
  (Dursun B, et al. J Diabetes Complications. 2009 Jul-Aug;23(4):257-64. Epub 2008 Apr 16.)
  View Abstract
• Biochemical evidence of atherosclerosis progression mediated by increased oxidative stress in apolipoprotein E-deficient spontaneously hyperlipidemic mice exposed to chronic cigarette smoke.
  (Kunitomo M, et al. J Pharmacol Sci. 2009 Jul;110(3):354-61. Epub 2009 Jul 1.)
  View Abstract
• 5-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein e-deficient mice by reducing superoxide production.
  (Shimada K, et al. Circ J. 2009 Jul;73(7):1337-41. Epub 2009 May 12.)
  View Abstract

• Early life origins of low-grade inflammation and atherosclerosis risk in children and adolescents.
  (Labayen I, et al. J Pediatr. 2009 Jul 10. [Epub ahead of print])
  View Abstract
• The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease.
  (Dursun I, et al. Nephrol Dial Transplant. 2009 Aug;24(8):2511-8. Epub 2009 Feb 24.)
  View Abstract
• Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice.
  (Gu H, et al. J Biomed Biotechnol. 2009;2009:613879. Epub 2009 Aug 27.)
  View Abstract
• Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth.
  (Morrison KM, et al. Atherosclerosis. 2009 Jul 23. [Epub ahead of print])
  View Abstract
• An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statin.
  (Ohshiro T, et al. J Atheroscler Thromb. 2009 Aug 27. [Epub ahead of print])
  View Abstract

LIFESTYLE

• Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study.
  (Monda KL, et al. J Lipid Res. 2009 Aug;50(8):1685-91. Epub 2009 Apr 3.)
  View Abstract
• Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study.
  (Möhlenkamp S, et al. Clin Res Cardiol. 2009 Aug 20. [Epub ahead of print])
  View Abstract
• Cross-sectional and longitudinal association of cigarette smoking with carotid atherosclerosis in Chinese adults.
  (Liang LR, et al. Prev Med. 2009 Aug;49(1):62-7. Epub 2009 May 22.)
  View Abstract
  

PLAQUE BIOLOGY

• Expression and location of intracellular tissue factor in atherosclerosis stable plaque of ApoE(-/-) mice.
  (Li J, et al. J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):457-61. Epub 2009 Aug 7.)
  View Abstract

RENAL / KIDNEY DISEASE

• Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.
  (Kestenbaum BR, et al. Kidney Int. 2009 Aug 19. [Epub ahead of print])
  View Abstract
• Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival.
  (Balsam A, et al. Hemodial Int. 2009 Jul;13(3):278-85. Epub 2009 Jul 15.)
  View Abstract

• Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis.
  (Ekuni D, et al. J Periodontal Res. 2009 Aug;44(4):434-42. Epub 2009 Feb 6.)
  View Abstract
• Approach to estimating participant pollutant exposures in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air).
  (Cohen MA, et al. Environ Sci Technol. 2009 Jul 1;43(13):4687-93.)
  View Abstract
• The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
  (Berneis K, et al. Clin Chim Acta. 2009 Aug;406(1-2):36-40. Epub 2009 May 9.)
  View Abstract
• Atherosclerosis risk factors in systemic lupus erythematosus.
  (Agarwal S, et al. Curr Rheumatol Rep. 2009 Aug;11(4):241-7.)
  View Abstract
• Ethnicity and risk factors for change in the ankle-brachial index: The Multi-Ethnic Study of Atherosclerosis.
  (Allison MA, et al. J Vasc Surg. 2009 Jul 21. [Epub ahead of print])
  View Abstract
• Risk of dementia hospitalization associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study.
  (Alonso A, et al. J Neurol Neurosurg Psychiatry. 2009 Aug 19. [Epub ahead of print])
  View Abstract
• Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.
  (Alonso A, et al. Am Heart J. 2009 Jul;158(1):111-7.)
  View Abstract
• Are Hodgkin and non-Hodgkin patients at a greater risk of atherosclerosis? A follow-up of 3 years.
  (Bilora F, et al. Eur J Cancer Care (Engl). 2009 Aug 26. [Epub ahead of print])
  View Abstract
• Risk factors for atherosclerosis in cases with severe periodontitis.
  (Buhlin K, et al. J Clin Periodontol. 2009 Jul;36(7):541-9.)
  View Abstract
• The relationship between self-reported history of endodontic therapy and coronary heart disease in the atherosclerosis risk in communities study.
  (Caplan DJ, et al. J Am Dent Assoc. 2009 Aug;140(8):1004-12.)
  View Abstract
• Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players.
  (Chang AY, et al. Am J Cardiol. 2009 Sep 15;104(6):805-11. Epub 2009 Jul 18.)
  View Abstract
• Increased risk for atherosclerosis of various macrophage scavenger receptor 1 alleles.
  (Durst R, et al. Genet Test Mol Biomarkers. 2009 Aug 29. [Epub ahead of print])
  View Abstract
• Cloninger's temperament traits and preclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
  (Hintsanen M, et al. J Psychosom Res. 2009 Jul;67(1):77-84. Epub 2009 Mar 3.)
  View Abstract
• Coronary artery disease patient's first degree relatives may be at higher risk for atherosclerosis.
  (Jha HC, et al. Int J Cardiol. 2009 Jul 10;135(3):408-9; author reply 410. Epub 2008 Jun 24.)
  View Abstract
• The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis.
  (Kablak-Ziembicka A, et al. Atherosclerosis. 2009 Aug 19. [Epub ahead of print])
  View Abstract
• Immigration presents a potential increased risk for atherosclerosis.
  (Lear SA, et al. Atherosclerosis. 2009 Aug;205(2):584-9. Epub 2009 Jan 9.)
  View Abstract
• Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
  (Nordestgaard BG, et al. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. Epub 2009 Aug 19.)
  View Abstract
• Iron in arterial plaque: modifiable risk factor for atherosclerosis.
  (Sullivan JL. Biochim Biophys Acta. 2009 Jul;1790(7):718-23. Epub 2008 Jun 19. Review.)
  View Abstract
• Periodontitis and risk for atherosclerosis: an update on intervention trials.
  (Tonetti MS. J Clin Periodontol. 2009 Jul;36 Suppl 10:15-9. Review.)
  View Abstract
• More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
  (Alexandroff AB, et al. Br J Dermatol. 2009 Jul;161(1):1-7. Epub 2009 Jun 4.)
  View Abstract
• The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Ding J, et al. Am J Clin Nutr. 2009 Sep;90(3):499-504. Epub 2009 Jul 1.)
  View Abstract
• Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Winston GJ, et al. Diabetes Care. 2009 Aug;32(8):1467-9. Epub 2009 May 12.)
  View Abstract
• Hopelessness, depressive symptoms, and carotid atherosclerosis in women. The Study of Women's Health Across the Nation (SWAN) Heart Study.
  (Whipple MO, et al. Stroke. 2009 Aug 27. [Epub ahead of print])
  View Abstract
• The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.
  (Rizzo M, et al. Intern Med J. 2009 Aug;39(8):539-45. Epub 2009 Mar 23.)
  View Abstract
• Progression of atherosclerosis in the Apo E-/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet.
  (von Holt K, et al. Atherosclerosis. 2009 Jul;205(1):135-43. Epub 2008 Dec 6.)
  View Abstract

STROKE

• Lesion patterns and stroke mechanisms in concurrent atherosclerosis of intracranial and extracranial vessels.
  (Man BL, et al. Stroke. 2009 Jul 30. [Epub ahead of print])
  View Abstract
• Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.
  (Folsom AR, et al. J Thromb Haemost. 2009 Aug 19. [Epub ahead of print])
  View Abstract

• Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases.
  (de la Cuesta F, et al. Expert Rev Proteomics. 2009 Aug;6(4):395-409.)
  View Abstract
• Transgenic expression of matrix metalloproteinase-9 modulates collagen deposition in a mouse model of atherosclerosis.
  (Lemaître V, et al. Atherosclerosis. 2009 Jul;205(1):107-12. Epub 2008 Dec 6.)
  View Abstract
• Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis.
  (Stintzing S, et al. Virchows Arch. 2009 Aug;455(2):171-85. Epub 2009 Jun 26.)
  View Abstract
• Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis.
  (Zhu L, et al. Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1039-45. Epub 2009 Apr 23.)
  View Abstract
• Correlation between carotid intimal/medial thickness and atherosclerosis. A point of view from pathology.
  (Finn AV, et al. Arterioscler Thromb Vasc Biol. 2009 Aug 13. [Epub ahead of print])
  View Abstract
• Macrophage diversity and polarization in atherosclerosis: a question of balance.
  (Mantovani A, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1419-23. Epub 2009 Aug 20.)
  View Abstract
• Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report.
  (Shagdarsuren E, et al. Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1161-3. Epub 2009 Jun 11.)
  View Abstract
• Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis.
  (Ueland T, et al. Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1228-34. Epub 2009 Jun 4.)
  View Abstract
• Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice.
  (Westmuckett AD, et al. Arterioscler Thromb Vasc Biol. 2009 Aug 13. [Epub ahead of print])
  View Abstract
• Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.
  (De Meyer T, et al. Eur Heart J. 2009 Aug 17. [Epub ahead of print])
  View Abstract
• The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis.
  (Deveci OS, et al. Angiology. 2009 Jul 31. [Epub ahead of print])
  View Abstract
• Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.
  (Brunetti ND, et al. J Thromb Thrombolysis. 2009 Jul;28(1):50-6. Epub 2008 Aug 9.)
  View Abstract
• Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis.
  (Civelek M, et al. Circ Res. 2009 Aug 28;105(5):453-61. Epub 2009 Aug 6.)
  View Abstract
• Clinical significance of serum 7-ketocholesterol concentrations in the progression of coronary atherosclerosis.
  (Hitsumoto T, et al. J Atheroscler Thromb. 2009 Aug;16(4):363-70. Epub 2009 Aug 11.)
  View Abstract
• Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study.
  (Hairston KG, et al. Diabetes Care. 2009 Aug;32(8):1553-5. Epub 2009 Jun 1.)
  View Abstract
• Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.
  (Hamilton JR, et al. Atherosclerosis. 2009 Aug;205(2):427-32. Epub 2009 Jan 23.)
  View Abstract
• Vasa vasorum hypoxia: initiation of atherosclerosis.
  (Järvilehto M, et al. Med Hypotheses. 2009 Jul;73(1):40-1. Epub 2009 Mar 4.)
  View Abstract
• Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.
  (Kaschina E, et al. Atherosclerosis. 2009 Aug;205(2):396-403. Epub 2009 Jan 13.)
  View Abstract
• Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis.
  (Kazanis K, et al. Clin Chim Acta. 2009 Oct;408(1-2):65-9. Epub 2009 Jul 19.)
  View Abstract
• Increased leukocyte aggregates are associated with atherosclerosis in patients with hemodialysis.
  (Kobayashi S, et al. Hemodial Int. 2009 Jul;13(3):286-92. Epub 2009 Jul 3.)
  View Abstract
• Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis.
  (Lee JR, et al. Arch Pharm Res. 2009 Aug;32(8):1109-18. Epub 2009 Aug 29.)
  View Abstract
• Association of high body lead store with severe intracranial carotid atherosclerosis.
  (Lee TH, et al. Neurotoxicology. 2009 Jul 16. [Epub ahead of print])
  View Abstract
• Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
  (Li K, et al. Cell Res. 2009 Aug;19(8):1006-17.)
  View Abstract
• Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
  (Liang KW, et al. Clin Chim Acta. 2009 Jul;405(1-2):114-8. Epub 2009 May 3.)
  View Abstract
• The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
  (Lievens D, et al. Thromb Haemost. 2009 Aug;102(2):206-14.)
  View Abstract
• Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.
  (Lindsey JB, et al. Diabetes Care. 2009 Jul;32(7):1218-20. Epub 2009 Apr 14.)
  View Abstract
• Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
  (Liu J, et al. Circ Res. 2009 Jul 31;105(3):295-303. Epub 2009 Jul 9.)
  View Abstract
• New insights in atherosclerosis: Endothelial shear stress as promoter rather than initiator.
  (Mehdizadeh A, et al. Med Hypotheses. 2009 Jul 2. [Epub ahead of print])
  View Abstract
• Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis.
  (Montecucco F, et al. Atherosclerosis. 2009 Aug;205(2):433-41. Epub 2009 Jan 9.)
  View Abstract
• Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice.
  (Poeckel D, et al. J Biol Chem. 2009 Jul 31;284(31):21077-89. Epub 2009 Jun 9.)
  View Abstract
• The fate of monocytes in atherosclerosis.
  (Randolph GJ. J Thromb Haemost. 2009 Jul;7 Suppl 1:28-30.)
  View Abstract
• Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis.
  (Ranjit N, et al. Psychosom Med. 2009 Sep;71(7):748-55. Epub 2009 Jul 10.)
  View Abstract
• Age, increased left ventricular mass, and lower regional myocardial perfusion are related to greater extent of myocardial dyssynchrony in asymptomatic individuals: the multi-ethnic study of atherosclerosis.
  (Rosen BD, et al. Circulation. 2009 Sep 8;120(10):859-66. Epub 2009 Aug 24.)
  View Abstract
• The factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a two year longitudinal study.
  (Rúa-Figueroa I, et al. Ann Rheum Dis. 2009 Aug 16. [Epub ahead of print])
  View Abstract
• How much is too much? Interleukin-6 and its signalling in atherosclerosis.
  (Schuett H, et al. Thromb Haemost. 2009 Aug;102(2):215-22.)
  View Abstract
• Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis.
  (Schumacher HC, et al. J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S451-73.)
  View Abstract
• Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease.
  (Silvestrini M, et al. Neurobiol Aging. 2009 Aug;30(8):1177-83. Epub 2008 Feb 20.)
  View Abstract
• Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis.
  (Sturm W, et al. Eur Heart J. 2009 Aug;30(16):2038-43. Epub 2009 Jun 4.)
  View Abstract
• Classification and Atherosclerosis Distribution in Patients with Left Main Coronary Disease.
  (Thompson CA, et al. J Interv Cardiol. 2009 Jul 13. [Epub ahead of print])
  View Abstract
• Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
  (van Es T, et al. Biochem Biophys Res Commun. 2009 Oct 16;388(2):261-5. Epub 2009 Aug 4.)
  View Abstract
• Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.
  (Xanthoulea S, et al. PLoS One. 2009 Jul 7;4(7):e6113.)
  View Abstract
• Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
  (Xu G, et al. Circ Res. 2009 Aug 28;105(5):500-10. Epub 2009 Jul 30.)
  View Abstract
• Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.
  (Yeboah J, et al. Circulation. 2009 Aug 11;120(6):502-9. Epub 2009 Jul 27.)
  View Abstract
• Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry.
  (Zhang F, et al. Talanta. 2009 Aug 15;79(3):836-44. Epub 2009 May 19.)
  View Abstract

VASCULAR CALCIFICATION

• The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
  (Ivanovski O, et al. Atherosclerosis. 2009 Jul;205(1):55-62. Epub 2008 Nov 18.)
  View Abstract
• Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification.
  (Burton DG, et al. Exp Gerontol. 2009 Jul 23. [Epub ahead of print])
  View Abstract

The following articles were recommended by Eder Quintão, MD

• Alterations in cholesterol absorption and synthesis characterize Framingham offspring study participants with coronary heart disease.
  (Matthan NR, et al. J Lipid Res. 2009 May 12.)
  View Abstract
• Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
  (Tanigawa H, et al. Circulation. 2009 Jul 14;120(2):160-9. Epub 2009 Jun 29)
  View Abstract
• 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.
  (Oh J, et al. Circulation. 2009 Aug 25;120(8):687-98. Epub 2009 Aug 10.)
  View Abstract
• Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
  (Calabresi L, et al. Circulation. 2009 Aug 18;120(7):628-35.)
  View Abstract
• Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. (Chakravarthy MV, et al. Cell. 2009 Aug 7;138(3):476-88. Epub 2009 Jul 30.)
  View Abstract
• Statins and angiogenesis: is it about connections?
  (Khaidakov M, et al. Biochem Biophys Res Commun. 2009 Sep 25;387(3):543-7.)
  View Abstract
• Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
  (de Vries-van der Weij J, Atherosclerosis. 2009 Sep;206(1):153-8.)
  View Abstract
• Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
  (Wiersma H, et al. Atherosclerosis. 2009 Sep;206(1):141-7.)
  View Abstract
• A common variant in low-density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol.
  (Tomaszewski M, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1316-21.)
  View Abstract
• Identification of genetic variants associated with response to statin therapy.
  (Mega JL, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1310-5.
  View Abstract
• Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
  (Gordts PL, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1258-64.)
  View Abstract